Exploring the salivary proteome following intraglandular mesenchymal stromal cell therapy for radiation-induced hyposalivation in previous head and neck cancer patients: a secondary study protocol for the MESRIX-III, randomised, controlled trial. - Carlander AF; Jakobsen KK; Jersie-Christensen R; Hansen J; Bendtsen SK; Kastrup J; Belstrøm D; Lynggard CD; Grønhøj C; von Buchwald C (Trials, 2025)